Clinical Trial Update: Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update comparing tamoxifen to toremifene in premenopausal women with ER-positive early breast cancer who are CYP2D6 intermediate or poo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Tamoxifen (tamoxifen)
• Toremifene (toremifene)

Snippet

Sponsor: Chinese Anti-Cancer Association | Conditions: Breast Cancer Female | Phase 3 | Status: UNKNOWN